<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39417786</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 Pandemic on Pediatric Bacterial Community-Acquired Pneumonia: A Multicenter Retrospective Study in Madrid (Spain).</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000004586</ELocationID><Abstract><AbstractText>This study conducted in Madrid (Spain) between 2018 and 2023 shows a significant decrease in the pediatric bacterial community-acquired pneumonia cases during the COVID-19 pandemic, followed by a notable postpandemic increase surpassing prepandemic incidence. Streptococcus pneumoniae remains predominant, with an increasing prevalence of serotype 3, while Streptococcus pyogenes was the second most common pathogen.</AbstractText><CopyrightInformation>Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguilera-Alonso</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1017-2386</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Pediatric Infectious Diseases Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Investigación Materno-Infantil Fundación Familia Alonso, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sánchez-Cañete</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ventura McArdle</LastName><ForeName>Leyre</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Rosal</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz Santaeufemia</LastName><ForeName>Francisco José</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Paediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saavedra-Lozano</LastName><ForeName>Jesús</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Pediatric Infectious Diseases Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Investigación Materno-Infantil Fundación Familia Alonso, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto Tato</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Hospital Universitario Doce de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez Álvarez</LastName><ForeName>Francisco José</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassy Navarro</LastName><ForeName>Sofía</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cercenado</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital General Universitario Gregorio Marañón, CIBER de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marín</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivas</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cendejas Bueno</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González Abad</LastName><ForeName>María José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital Universitario Niño Jesús, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina Arana</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Hospital de Getafe, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuste</LastName><ForeName>José</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Spanish Pneumococcal Reference Laboratory, National Centre for Microbiology, CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baquero-Artigao</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CIBER en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CIBER en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>The authors have no funding or conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39417786</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000004586</ArticleId><ArticleId IdType="pii">00006454-990000000-01056</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen PR, Rybak A, Werner A, et al. Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: a prospective multicentric surveillance study in France. Lancet Reg Health Eur. 2022;22:100497.</Citation></Reference><Reference><Citation>Izu A, Nunes MC, Solomon F, et al. All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study. Lancet Infect Dis. 2023;23:1031–1041.</Citation></Reference><Reference><Citation>Bertran M, D’Aeth JC, Abdullahi F, et al. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study. Lancet Infect Dis. 2024;24:546–556.</Citation></Reference><Reference><Citation>Abo YN, Oliver J, McMinn A, et al. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac. 2023;41:100873.</Citation></Reference><Reference><Citation>Rubin RMA. From “Immunity Debt” to “Immunity theft”-How COVID-19 might be tied to recent respiratory disease surges. JAMA. 2024;331:378–381.</Citation></Reference><Reference><Citation>Levy R, Cohen R, Lev-Shalem L, et al. A retrospective database analysis of before and after social distancing in relation to pediatric infection rate and healthcare services usage during the coronavirus disease 2019 pandemic. Clin Infect Dis. 2023;76:713–719.</Citation></Reference><Reference><Citation>Dagan R, van der Beek BA, Ben-Shimol S, et al. The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study. EBioMedicine. 2023;90:104493.</Citation></Reference><Reference><Citation>Cobo-Vázquez E, Aguilera-Alonso D, Carrasco-Colom J, et al.; PedGAS-net Working Group. Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019-2022. Lancet Reg Health Eur. 2023;27:100597.</Citation></Reference><Reference><Citation>Pérez-García C, Sempere J, de Miguel S, et al. Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023). J Infect. 2024;89:106204.</Citation></Reference><Reference><Citation>Hernández S, Moraga-Llop F, Díaz A, et al. Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2–59 months of age, Spain. Emerg Infect Dis. 2020;26:1147–1155.</Citation></Reference><Reference><Citation>Aguilera-Alonso D, Nieto SK, Montojo MFA, et al. Staphylococcus aureus Community-acquired pneumonia in children after 13-valent pneumococcal vaccination (2008-2018): Epidemiology, clinical characteristics and outcomes. Pediatr Infect Dis J. 2022;41:E235–E242.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>